Dataset Information

AE-MS to profile SLO-human plasma protein interactome landscape; HDX-MS and XL-MS to study protein interaction and dynamics of PLG-SLO

ABSTRACT: Group A Streptococcus is known to exploit the human fibrinolysis system, particularly by targeting the plasminogen/plasmin pathway through redundant pathomechanisms. In this study, we began with affinity-enrichment mass spectrometry to map the interaction landscape between streptolysin O and human plasma, identifying human plasminogen as a specific binder to the streptolysin O. Subsequent biochemical assays validated this direct interaction and demonstrated the streptolysin O's role in enhancing tPA-mediated plasmin production. We then employed HDX-MS and XL-MS to further explore and characterize the molecular details of the plasminogen-streptolysin O complex formation, shedding light on its biological significance.

INSTRUMENT(S):

ORGANISM(S): Streptococcus Pyogenes Mgas315 Homo Sapiens (human)

TISSUE(S): Blood Plasma

SUBMITTER: Di Tang

LAB HEAD: Johan Malmström

PROVIDER: PXD051261 | Pride | 2024-10-17

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	00s_plg_20230510_142935_0.raw	Raw
	00s_plg_20230510_193254_0.raw	Raw
	00s_plg_20230511_003538_0.raw	Raw
	3000s_plg_20230510_173050_3000.raw	Raw
	3000s_plg_20230510_223347_3000.raw	Raw

Items per page:

1 - 5 of 99

Publications

Streptolysin O accelerates the conversion of plasminogen to plasmin.

Tang Di D Khakzad Hamed H Hjortswang Elisabeth E Malmström Lars L Ekström Simon S Happonen Lotta L Malmström Johan J

Nature communications 20241125 1

Group A Streptococcus (GAS) is a human-specific bacterial pathogen that can exploit the plasminogen-plasmin fibrinolysis system to dismantle blood clots and facilitate its spread and survival within the human host. In this study, we use affinity-enrichment mass spectrometry to decipher the host-pathogen protein-protein interaction between plasminogen and streptolysin O, a key cytolytic toxin produced by GAS. This interaction accelerates the conversion of plasminogen to plasmin by both the host t ...[more]

PMID: 39587097

Similar Datasets

Project description:Venkatraman2011 - PLS-UPA behaviour in the presence of substrate competition The posibility of ultrasensitivity and bistable activation of PLS (Plasmin) and UPA (Urokinase-type plasminogen activator) in the presence of substrate competition is explained here using a mathematical model. This model is described in the article: Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro. Venkatraman L, Li H, Dewey CF Jr, White JK, Bhowmick SS, Yu H, Tucker-Kellogg L. Biophys. J. 2011 Oct; 101(8): 1825-1834 Abstract: Plasmin (PLS) and urokinase-type plasminogen activator (UPA) are ubiquitous proteases that regulate the extracellular environment. Although they are secreted in inactive forms, they can activate each other through proteolytic cleavage. This mutual interplay creates the potential for complex dynamics, which we investigated using mathematical modeling and in vitro experiments. We constructed ordinary differential equations to model the conversion of precursor plasminogen into active PLS, and precursor urokinase (scUPA) into active urokinase (tcUPA). Although neither PLS nor UPA exhibits allosteric cooperativity, modeling showed that cooperativity occurred at the system level because of substrate competition. Computational simulations and bifurcation analysis predicted that the system would be bistable over a range of parameters for cooperativity and positive feedback. Cell-free experiments with recombinant proteins tested key predictions of the model. PLS activation in response to scUPA stimulus was found to be cooperative in vitro. Finally, bistability was demonstrated in vitro by the presence of two significantly different steady-state levels of PLS activation for the same levels of stimulus. We conclude that ultrasensitive, bistable activation of UPA-PLS is possible in the presence of substrate competition. An ultrasensitive threshold for activation of PLS and UPA would have ramifications for normal and disease processes, including angiogenesis, metastasis, wound healing, and fibrosis. The cooperativity parameter "ci" was missing in the original model. The parameter "ci" has been added to the added. This model is hosted on BioModels Database and identified by: BIOMD0000000630. To cite BioModels Database, please use: BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.